Nomenclature for Factors of the HLA System 1984
The HLA nomenclature committee met under the auspices of the WHO after the 9th International Histocompatibility Testing Workshop to consider revisions and additions to the nomenclature of factors identified by serological and cellular typing following the principles established successively in previous reports [1–6]. The nomenclature for the variants of the complement components controlled by genes of the HLA region was not considered as it was assumed that this was the responsibility of those with a special interest in complement, see e.g. . Special attention was given to establishing a revised system of nomenclature for the products (sometimes called class II) of what can now be called the HLA-D region, based on the recent advances in our understanding of the biochemistry and genetics of these products.
KeywordsPrefix Clarification Cali
Unable to display preview. Download preview PDF.
- 1.Bulletin of the World Health Organization (1968) 39:483Google Scholar
- 2.WHO terminology report, Histocompatibility Testing 1970, p49, Terasaki PI ed, Munksgaard, Copenhagen 1970Google Scholar
- 3.Bulletin of the World Health Organization (1972) 47:659Google Scholar
- 4.Bulletin of the World Health Organization (1975) 52:261Google Scholar
- 5.Bulletin of the World Health Organization (1978) 56:461Google Scholar
- 6.Histocompatibility Testing 1980, Terasaki PI ed, UCLA Tissue Typing Laboratory, Los Angeles, Calif, p 18–20, 1980Google Scholar
- 7.Statement on the Nomenclature of Human C4 Allotypes. Mauff G, Alper CA, Awdeh Z, Batchelor JR, Bertrams J, Bruun-Petersen G, Dawkins RL, Demant P, Edwards J, Grosse-Wilde H, Hauptmann G, Klouda P, Lamm L, Mollenhauer E, Nerl C, Olaisen B, O’Neill G, Rittner C, Roos MH, Skanes V, Teisberg P, Wells L. Immunobiology, vol. 164, pp 184 - 191 (1983)PubMedCrossRefGoogle Scholar
- 8.Histocompatibility Testing 1984, Albert ED, Baur MP, Mayr WR eds, Springer Verlag, Heidelberg 1984Google Scholar